Skip to main content
Top
Published in: CardioVascular and Interventional Radiology 10/2019

01-10-2019 | Angiography | Clinical Investigation

Chemosaturation Percutaneous Hepatic Perfusion (CS-PHP) with Melphalan: Evaluation of 2D-Perfusion Angiography (2D-PA) for Leakage Detection of the Venous Double-Balloon Catheter

Authors: Cornelia L. A. Dewald, Timo C. Meine, Hinrich M. B. Winther, Roman Kloeckner, Sabine K. Maschke, Martha M. Kirstein, Arndt Vogel, Frank K. Wacker, Bernhard C. Meyer, Julius Renne, Jan B. Hinrichs

Published in: CardioVascular and Interventional Radiology | Issue 10/2019

Login to get access

Abstract

Purpose

To evaluate the feasibility of 2D-perfusion angiography (2D-PA) for detecting leakage of the double-balloon catheter used for chemosaturation percutaneous hepatic perfusion (CS-PHP).

Materials and Methods

Overall, 112 CS-PHP (09/2015-09/2018) in 52 patients were retrospectively screened for leakage alongside the double-balloon catheter on standard venograms. Finally, 18 procedures with visually detected leakage were included. Fifteen consecutive procedures without leakage served as control. To evaluate 2D-PA for leakage detection, the acquired digital subtraction venograms were post-processed. For each balloon, two different target ROIs were evaluated to assess a possible impact of localization and shape of the ROIs. Time to peak (TTP), peak density (PD), area under the curve (AUC), and ratios of target ROI/reference ROIs (PDtROI/PDREF; AUCtROI/AUCREF; and TTPtROI/TTPREF) were calculated.

Results

Leakages were located as follows: 15/18 cranial and 3/18 caudal. At the cranial balloon both ROIs showed a significant decrease in PDtROI/PDREF and AUCtROI/AUCREF (ROI1: p < 0.0001; p < 0.0001; ROI2: p < 0.0001; p < 0.0001) and a significant increase in TTPtROI/TTPREF (ROI1: p = 0.0009; ROI2: p = 0.0003) after double-balloon correction. Following balloon adjustment, the 2D-PA ratios (PD and AUC) of the tested ROIs differed significantly (p < 0.05). The inter-individual comparison of the 2D-PA parameters of the group with leakage before balloon correction and the non-leakage group showed significantly different 2D-PA values for the cranial balloon in both ROIs (p < 0.05). No significant differences were found for the caudal balloon.

Conclusion

2D-PA provides a feasible tool for detecting leakages alongside the cranial portion of the double-balloon catheter used in CS-PHP. The shape and position of the ROIs used to assess perfusion and flow have an impact on the measurements.
Literature
1.
go back to reference Hughes MS, Zager J, Faries M, Alexander HR, Royal RE, Wood B, et al. Results of a randomized controlled multicenter phase III trial of percutaneous hepatic perfusion compared with best available care for patients with melanoma liver metastases. Ann Surg Oncol. 2016;23:1309–19.CrossRefPubMed Hughes MS, Zager J, Faries M, Alexander HR, Royal RE, Wood B, et al. Results of a randomized controlled multicenter phase III trial of percutaneous hepatic perfusion compared with best available care for patients with melanoma liver metastases. Ann Surg Oncol. 2016;23:1309–19.CrossRefPubMed
2.
go back to reference Marquardt S, Kirstein MM, Brüning R, Zeile M, Ferrucci PF, Prevoo W, et al. Percutaneous hepatic perfusion (chemosaturation) with melphalan in patients with intrahepatic cholangiocarcinoma: European multicentre study on safety, short-term effects and survival. Eur Radiol. 2018;383:2168. Marquardt S, Kirstein MM, Brüning R, Zeile M, Ferrucci PF, Prevoo W, et al. Percutaneous hepatic perfusion (chemosaturation) with melphalan in patients with intrahepatic cholangiocarcinoma: European multicentre study on safety, short-term effects and survival. Eur Radiol. 2018;383:2168.
3.
go back to reference Kirstein MM, Marquardt S, Jedicke N, Marhenke S, Koppert W, Manns MP, et al. Safety and efficacy of chemosaturation in patients with primary and secondary liver tumors. J Cancer Res Clin Oncol. 2017;143:2113–21.CrossRefPubMed Kirstein MM, Marquardt S, Jedicke N, Marhenke S, Koppert W, Manns MP, et al. Safety and efficacy of chemosaturation in patients with primary and secondary liver tumors. J Cancer Res Clin Oncol. 2017;143:2113–21.CrossRefPubMed
4.
go back to reference Forster MR, Rashid OM, Perez MC, Choi J, Chaudhry T, Zager JS. Chemosaturation with percutaneous hepatic perfusion for unresectable metastatic melanoma or sarcoma to the liver: a single institution experience. J Surg Oncol. 2014;109:434–9.CrossRefPubMed Forster MR, Rashid OM, Perez MC, Choi J, Chaudhry T, Zager JS. Chemosaturation with percutaneous hepatic perfusion for unresectable metastatic melanoma or sarcoma to the liver: a single institution experience. J Surg Oncol. 2014;109:434–9.CrossRefPubMed
5.
go back to reference Vogel A, Gupta S, Zeile M, von Haken R, Brüning R, Lotz G, et al. Chemosaturation percutaneous hepatic perfusion: a systematic review. Adv Ther. 2017;33:2122–38.CrossRefPubMed Vogel A, Gupta S, Zeile M, von Haken R, Brüning R, Lotz G, et al. Chemosaturation percutaneous hepatic perfusion: a systematic review. Adv Ther. 2017;33:2122–38.CrossRefPubMed
6.
go back to reference de Leede EM, Burgmans MC, Meijer TS, Martini CH, Tijl FGJ, Vuyk J, et al. Prospective clinical and pharmacological evaluation of the Delcath System’s second-generation (GEN2) hemofiltration system in patients undergoing percutaneous hepatic perfusion with melphalan. Cardiovasc Interv Radiol. 2017;40:1196–205.CrossRef de Leede EM, Burgmans MC, Meijer TS, Martini CH, Tijl FGJ, Vuyk J, et al. Prospective clinical and pharmacological evaluation of the Delcath System’s second-generation (GEN2) hemofiltration system in patients undergoing percutaneous hepatic perfusion with melphalan. Cardiovasc Interv Radiol. 2017;40:1196–205.CrossRef
7.
go back to reference McEwan PE, Bailey L, Trost D, Scull C, Keating JH, Williams M, et al. Percutaneous hepatic perfusion with filtered melphalan for localized treatment of metastatic hepatic disease: a risk assessment. Int J Toxicol. 2018;37:1091581818811306–447.CrossRef McEwan PE, Bailey L, Trost D, Scull C, Keating JH, Williams M, et al. Percutaneous hepatic perfusion with filtered melphalan for localized treatment of metastatic hepatic disease: a risk assessment. Int J Toxicol. 2018;37:1091581818811306–447.CrossRef
8.
go back to reference Maschke SK, Renne J, Werncke T, Olsson KM, Hoeper MM, Wacker FK, et al. Chronic thromboembolic pulmonary hypertension: evaluation of 2D-perfusion angiography in patients who undergo balloon pulmonary angioplasty. Eur Radiol. 2017;27:4264–70.CrossRefPubMed Maschke SK, Renne J, Werncke T, Olsson KM, Hoeper MM, Wacker FK, et al. Chronic thromboembolic pulmonary hypertension: evaluation of 2D-perfusion angiography in patients who undergo balloon pulmonary angioplasty. Eur Radiol. 2017;27:4264–70.CrossRefPubMed
9.
go back to reference Maschke SK, Werncke T, Klöckner R, Rodt T, Renne J, Kirstein MM, et al. Quantification of perfusion reduction by using 2D-perfusion angiography following transarterial chemoembolization with drug-eluting beads. Abdom Radiol (NY). 2017;65:87–9. Maschke SK, Werncke T, Klöckner R, Rodt T, Renne J, Kirstein MM, et al. Quantification of perfusion reduction by using 2D-perfusion angiography following transarterial chemoembolization with drug-eluting beads. Abdom Radiol (NY). 2017;65:87–9.
10.
go back to reference Maschke SK, Werncke T, Renne J, Kloeckner R, Marquardt S, Kirstein MM, et al. Transjugular intrahepatic portosystemic shunt (TIPS) dysfunction: quantitative assessment of flow and perfusion changes using 2D-perfusion angiography following shunt revision. Abdom Radiol (NY). 2018;43:2868–75.CrossRef Maschke SK, Werncke T, Renne J, Kloeckner R, Marquardt S, Kirstein MM, et al. Transjugular intrahepatic portosystemic shunt (TIPS) dysfunction: quantitative assessment of flow and perfusion changes using 2D-perfusion angiography following shunt revision. Abdom Radiol (NY). 2018;43:2868–75.CrossRef
11.
go back to reference Murray T, Rodt T, Lee MJ. Two-dimensional perfusion angiography of the foot: technical considerations and initial analysis. J Endovasc Ther. 2016;23:58–64.CrossRefPubMed Murray T, Rodt T, Lee MJ. Two-dimensional perfusion angiography of the foot: technical considerations and initial analysis. J Endovasc Ther. 2016;23:58–64.CrossRefPubMed
12.
go back to reference Reekers JA, Koelemay MJW, Marquering HA, van Bavel ET. Functional imaging of the foot with perfusion angiography in critical limb ischemia. Cardiovasc Interv Radiol. 2016;39:183–9.CrossRef Reekers JA, Koelemay MJW, Marquering HA, van Bavel ET. Functional imaging of the foot with perfusion angiography in critical limb ischemia. Cardiovasc Interv Radiol. 2016;39:183–9.CrossRef
13.
go back to reference Zhou M, Su Z, Shi Z, Fu W, Meng X, Wang Y, et al. Application of color-coded quantitative digital subtraction angiography in predicting the outcomes of immediate type I and type III endoleaks. J Vasc Surg. 2017;66:760–7.CrossRefPubMed Zhou M, Su Z, Shi Z, Fu W, Meng X, Wang Y, et al. Application of color-coded quantitative digital subtraction angiography in predicting the outcomes of immediate type I and type III endoleaks. J Vasc Surg. 2017;66:760–7.CrossRefPubMed
14.
go back to reference Tan RY, Chong TT, Tsai FC, Pang SC, Lee KG, Gogna A, et al. A pilot study on adjunctive use of parametric colour-coded digital subtraction angiography in endovascular interventions of haemodialysis access. BMC Med Imaging. 2018;18:28.CrossRefPubMedPubMedCentral Tan RY, Chong TT, Tsai FC, Pang SC, Lee KG, Gogna A, et al. A pilot study on adjunctive use of parametric colour-coded digital subtraction angiography in endovascular interventions of haemodialysis access. BMC Med Imaging. 2018;18:28.CrossRefPubMedPubMedCentral
15.
go back to reference Burgmans MC, de Leede EM, Martini CH, Kapiteijn E, Vahrmeijer AL, van Erkel AR. percutaneous isolated hepatic perfusion for the treatment of unresectable liver malignancies. Cardiovasc Interv Radiol. 2016;39:801–14.CrossRef Burgmans MC, de Leede EM, Martini CH, Kapiteijn E, Vahrmeijer AL, van Erkel AR. percutaneous isolated hepatic perfusion for the treatment of unresectable liver malignancies. Cardiovasc Interv Radiol. 2016;39:801–14.CrossRef
16.
go back to reference Hinrichs JB, Murray T, Akin M, Lee M, Brehm MU, Wilhelmi M, et al. Evaluation of a novel 2D perfusion angiography technique independent of pump injections for assessment of interventional treatment of peripheral vascular disease. Int J Cardiovasc Imaging. 2017;33:295–301.CrossRefPubMed Hinrichs JB, Murray T, Akin M, Lee M, Brehm MU, Wilhelmi M, et al. Evaluation of a novel 2D perfusion angiography technique independent of pump injections for assessment of interventional treatment of peripheral vascular disease. Int J Cardiovasc Imaging. 2017;33:295–301.CrossRefPubMed
17.
go back to reference Karydis I, Gangi A, Wheater MJ, Choi J, Wilson I, Thomas K, et al. Percutaneous hepatic perfusion with melphalan in uveal melanoma: a safe and effective treatment modality in an orphan disease. J Surg Oncol. 2018;117:1170–8.CrossRefPubMed Karydis I, Gangi A, Wheater MJ, Choi J, Wilson I, Thomas K, et al. Percutaneous hepatic perfusion with melphalan in uveal melanoma: a safe and effective treatment modality in an orphan disease. J Surg Oncol. 2018;117:1170–8.CrossRefPubMed
18.
go back to reference Jens S, Marquering HA, Koelemay MJW, Reekers JA. Perfusion angiography of the foot in patients with critical limb ischemia: description of the technique. Cardiovasc Interv Radiol. 2015;38:201–5.CrossRef Jens S, Marquering HA, Koelemay MJW, Reekers JA. Perfusion angiography of the foot in patients with critical limb ischemia: description of the technique. Cardiovasc Interv Radiol. 2015;38:201–5.CrossRef
19.
go back to reference Kim AH, Shevitz AJ, Morrow KL, Kendrick DE, Harth K, Baele H, et al. Characterizing tissue perfusion after lower extremity intervention using two-dimensional color-coded digital subtraction angiography. J Vasc Surg. 2017;66:1464–72.CrossRefPubMed Kim AH, Shevitz AJ, Morrow KL, Kendrick DE, Harth K, Baele H, et al. Characterizing tissue perfusion after lower extremity intervention using two-dimensional color-coded digital subtraction angiography. J Vasc Surg. 2017;66:1464–72.CrossRefPubMed
Metadata
Title
Chemosaturation Percutaneous Hepatic Perfusion (CS-PHP) with Melphalan: Evaluation of 2D-Perfusion Angiography (2D-PA) for Leakage Detection of the Venous Double-Balloon Catheter
Authors
Cornelia L. A. Dewald
Timo C. Meine
Hinrich M. B. Winther
Roman Kloeckner
Sabine K. Maschke
Martha M. Kirstein
Arndt Vogel
Frank K. Wacker
Bernhard C. Meyer
Julius Renne
Jan B. Hinrichs
Publication date
01-10-2019
Publisher
Springer US
Keyword
Angiography
Published in
CardioVascular and Interventional Radiology / Issue 10/2019
Print ISSN: 0174-1551
Electronic ISSN: 1432-086X
DOI
https://doi.org/10.1007/s00270-019-02243-4

Other articles of this Issue 10/2019

CardioVascular and Interventional Radiology 10/2019 Go to the issue